Become an Investigator
Opportunities for Clinical Trial Investigators
Be at the forefront life changing cancer vaccines, delivered off the shelf.
Scancell is a clinical stage biopharmaceutical company developing novel immune-oncology therapies. Our goal is to give patients who have unresponsive tumours an increased chance of survival through durable and potent immune response to tumours.
With a track record of successfully delivering innovative science that is translated into the clinic. Our off the shelf cancer vaccines have robust GMP manufacturing process, stable shelf life and faster route to treatment allowing pricing flexibility and stability of 5 years.
“Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate novel medicines to treat significant unmet needs in cancer and infectious disease. We are poised to make a significant difference in how cancer is treated using innovative cancer vaccines. We are passionate about working with investigators collaboratively to advance medical research and define a new paradigm in improving outcomes for cancer patients.”
Dr Nermeen Varawalla
CHIEF MEDICAL OFFICER
In House Clinical Development Team
Our in house clinical operations team work seamlessly with investigator sites. This means our CRAs are highly engaged with clinical site through direct routes of communication. We operate with an agile and collaborative approach to clinical development, with investigators, research nurses and their cross-functional teams.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
